Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration

FierceBiotech‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game

Clinical OMICsHave Microbubbles Burst Through the Barriers of Genetic Medicine Delivery?

Clinical OMICsOLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia

Endpoints NewsFDA gives rejected drugs another chance in post-Makary era

Clinical OMICsAI Discovers Two New Antibiotics for Drug-Resistant Gonorrhea

Clinical OMICsGLP-1 Drugs Reduce Crime-Linked Behavior

Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer

Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered

Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM

Endpoints NewsFDA warns telehealth companies over compounded GLP-1s

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA